• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID:200901029457031234   Update date: Apr. 18, 2025

Takehara Tetsuo

タケハラ テツオ | Takehara Tetsuo
Clips
Affiliation and department:
Research field  (1): Gastroenterology
Research theme for competitive and other funds  (41):
  • 2022 - 2024 癌微小環境の形質的・空間的多様性を介したがん細胞クローン拡大機構の解明
  • 2021 - 2024 Elucidation of hepatic progenitor cell-derived carcinogenic mechanism via p53 activation in hepatocytes
  • 2018 - 2021 Elucidation of the mechanism of pancreatic cancer metastasis using single cell analysis technology and innovative mouse models
  • 2018 - 2021 Cell-to-cell communication and pathogenesis triggered by hepatocyte cell death in the liver
  • 2017 - 2019 障害ミトコンドリアからのダイイングコード漏出による脂肪性肝疾患の進展機序の解明
Show all
Papers (661):
  • Kai Y, Hikita H, Morishita N, Murai K, Nakabori T, Iio S, Hagiwara H, Imai Y, Tamura S, Tsutsui S, et al. Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment. Scientific Reports. 2107
  • Eiji Kimura, Yoshito Hayashi, Kentaro Nakagawa, Hirotsugu Saiki, Minoru Kato, Ryotaro Uema, Takanori Inoue, Takeo Yoshihara, Akihiko Sakatani, Hiromu Fukuda, et al. p53 Deficiency in Colon Cancer Cells Promotes Tumor Progression Through the Modulation of Meflin in Fibroblasts. Cancer science. 2025
  • Yoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi, Yoshitaka Inaba, Tatsuya Yamashita, Hideki Iwamoto, Makoto Ueno, Sadahisa Ogasawara, Teiji Kuzuya, Takahiro Kodama, et al. Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. BMC cancer. 2025. 25. 1. 434-434
  • Shinnosuke Kudo, Hayato Hikita, Yoshinobu Saito, Kazuhiro Murai, Takahiro Kodama, Tomohide Tatsumi, Tetsuo Takehara. Collaborative orchestration of BH3-only proteins governs Bak/Bax-dependent hepatocyte apoptosis under antiapoptotic protein-deficiency in mice. Cell death and differentiation. 2025
  • Kentaro Nakagawa, Yoshito Hayashi, Yujiro Adachi, Ayaka Tajiri, Hiromu Fukuda, Eiji Kimura, Ryotaro Uema, Hirotsugu Saiki, Minoru Kato, Takanori Inoue, et al. Low skeletal muscle mass contributes to the prognosis of patients with superficial esophageal cancer treated with definitive chemoradiotherapy. Esophagus : official journal of the Japan Esophageal Society. 2025
more...
MISC (1,387):
  • Akiyoshi Shimoda, Hayato Hikita, Kazuhiro Murai, Takayuki Miyake, Shinji Kuriki, Emi Sometani, Jihyun Sung, Satoshi Shigeno, Kumiko Shirai, Yuki Tahata, et al. FDA APPROVED DRUG LIBRARY SCREENING TO IDENTIFY COMPOUNDS THAT REDUCE HBS ANTIGEN. HEPATOLOGY. 2024. 80. S211-S212
  • Yoshinobu Saito Hayato Hikita, Tomoya Hamabe, Yoichi Sasaki, Shinnosuke Kudo, Kazuhiro Murai, Takahiro Kodama, Tetsuo Takehara. INVESTIGATION FOR A ROLE OF NON-APOPTOTIC CELL DEATH IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA. HEPATOLOGY. 2024. 80
  • Jihyun Sung, Hayato Hikita, Yuki Makino, Seiya Kato, Yoichi Sasaki, Kenji Fukumoto, Kazuhiro Murai, Yoshinobu Saito, Takahiro Kodama, Tomohide Tatsumi, et al. ACTIVATION OF HEPATOCYTE P53 TRIGGERS ACUTE LIVER FAILURE WITH MULTIPLE ORGAN INJURY. HEPATOLOGY. 2024. 80. S1583-S1584
  • Kazuhiro Murai, Hayato Hikita, Ryoko Yamada, Takayuki Miyake, Emi Sometani, Shinji Kuriki, Jihyun Sung, Akiyoshi Shimoda, Satoshi Shigeno, Yuki Tahata, et al. RISK FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA OCCURRENCE IN CHRONIC HEPATITIS B PATIENTS ON LONG-TERM NUCLEOS(T) IDE ANALOGUES. HEPATOLOGY. 2024. 80. S182-S182
  • Shuhei Yamamoto, Takahiro Kodama, Kazuki Maesaka, Akifumi Kuwano, Kenta Motomura, Kumiko Shirai, Akira Doi, Kazuhiro Murai, Yuki Tahata, Yoshinobu Saito, et al. NRF2-MEDIATED IMMUNE COLD TUMOR MICROENVIRONMENT CONTRIBUTES TO RESISTANCE TO ATEZOLIZUMAB AND BEVACIZUMAB IN ADVANCED HEPATOCELLULAR CARCINOMA. HEPATOLOGY. 2024. 80
more...
Works (3):
  • 肝癌幹細胞に対する癌免疫治療とその分子機構の解析
    2009 -
  • ナノテクノロジーを用いた樹状細胞活性化機構の解析と肝癌免疫治療
    2008 -
  • ナノテクノロジーを用いた樹状細胞活性化機構の解析と肝癌免疫治療
    2007 -
Professional career (1):
  • (BLANK) (Osaka University)
Committee career (2):
  • 日本肝臓学会 評議員
  • 日本消化器病学会 評議員
Awards (2):
  • 1997 - 日本内科学会奨励賞
  • 1996 - 日本肝臓学会研究奨励賞
Association Membership(s) (7):
日本肝臓学会 ,  日本癌学会 ,  日本内科学会 ,  日本免疫学会 ,  American Association for the Study of Liver Diseases ,  日本消化器病学会 ,  日本消化器内視鏡学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page